Armata Pharmaceuticals, Inc. Gains 103.17%

Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT) jumped higher at $7.05, a gain of 103.2%. On Wed, Oct 22, 2025, ARMP:NYSEMKT touched a New 2-Week High of $7.05. The stock got featured on our News Catalysts scanner on Wed, Oct 22, 2025 at 12:21 PM in the 'BIOTECH' category. From Wed, Oct 08, 2025, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Wed, Oct 22, 2025 at $16.34 with a volume of 12M+.

About Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.